Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/11/12

Trade details

Type: Insider sale
Amount: $1,367,329
Shares · price: 19,900 sh · $68.71 a share
Held after: 733,819 sh
Stock: Halozyme Therapeutics HALO
Person: Helen TorleyPresident and CEO
Trade date: 25/11/10
Filed: 25/11/12
Days to filing: 2 days

Sold 2.6% of holdings

Share of holding sold: 2.6%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/11~25/12/10

Helen Torley's recent trades

Helen TorleyPresident and CEO
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$23.7M
240,000 sh
$23.7M
Filed 08/17
Traded 08/17
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$1.1M
16,600 sh
$1.1M
Filed 06/03
Traded 06/02
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$875.6K
12,989 sh
$875.6K
Filed 06/03
Traded 06/01
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$425.1K
6,100 sh
$425.1K
Filed 06/03
Traded 06/03
Helen TorleyPresident and CEO
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$369.2K
5,401 sh
$369.2K
Filed 06/03
Traded 06/01

Helen Torley, CEO — sold $1.4M of Halozyme Therapeutics HALO · 2.6% of holdings · 10b5-1 plan | Whalegun